Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
CD34+ progenitor-derived NK cell and gemcitabine combination therapy increases killing of ovarian cancer cells in NOD/SCID/IL2Rgnull mice.
Van der Meer JMR, de Jonge PKJD, van der Waart AB, Geerlings AC, Moonen JP, Brummelman J, de Klein J, Vermeulen MC, Maas RJA, Schaap NPM, Hoogstad-van Evert JS, Ottevanger PB, Jansen JH, Hobo W, Dolstra H. Van der Meer JMR, et al. Among authors: van der waart ab. Oncoimmunology. 2021 Oct 1;10(1):1981049. doi: 10.1080/2162402X.2021.1981049. eCollection 2021. Oncoimmunology. 2021. PMID: 34616589 Free PMC article.
Polymorphisms in CCR6 are associated with chronic graft-versus-host disease and invasive fungal disease in matched-related hematopoietic stem cell transplantation.
Broen K, van der Waart AB, Greupink-Draaisma A, Metzig J, Feuth T, Schaap NP, Blijlevens NM, van der Velden WJ, Dolstra H. Broen K, et al. Among authors: van der velden wj, van der waart ab. Biol Blood Marrow Transplant. 2011 Oct;17(10):1443-9. doi: 10.1016/j.bbmt.2011.07.004. Epub 2011 Jul 18. Biol Blood Marrow Transplant. 2011. PMID: 21763254 Free article. Clinical Trial.
Decreased levels of circulating IL17-producing CD161+CCR6+ T cells are associated with graft-versus-host disease after allogeneic stem cell transplantation.
van der Waart AB, van der Velden WJ, van Halteren AG, Leenders MJ, Feuth T, Blijlevens NM, van der Voort R, Dolstra H. van der Waart AB, et al. Among authors: van der velden wj, van halteren ag, van der voort r. PLoS One. 2012;7(12):e50896. doi: 10.1371/journal.pone.0050896. Epub 2012 Dec 4. PLoS One. 2012. PMID: 23226545 Free PMC article.
Natural killer cells generated from cord blood hematopoietic progenitor cells efficiently target bone marrow-residing human leukemia cells in NOD/SCID/IL2Rg(null) mice.
Cany J, van der Waart AB, Tordoir M, Franssen GM, Hangalapura BN, de Vries J, Boerman O, Schaap N, van der Voort R, Spanholtz J, Dolstra H. Cany J, et al. Among authors: van der voort r, van der waart ab. PLoS One. 2013 Jun 5;8(6):e64384. doi: 10.1371/journal.pone.0064384. Print 2013. PLoS One. 2013. PMID: 23755121 Free PMC article.
Targeting the IL17 pathway for the prevention of graft-versus-host disease.
van der Waart AB, van der Velden WJ, Blijlevens NM, Dolstra H. van der Waart AB, et al. Among authors: van der velden wj. Biol Blood Marrow Transplant. 2014 Jun;20(6):752-9. doi: 10.1016/j.bbmt.2014.02.007. Epub 2014 Feb 22. Biol Blood Marrow Transplant. 2014. PMID: 24565991 Free article. Review.
Inhibition of Akt signaling promotes the generation of superior tumor-reactive T cells for adoptive immunotherapy.
van der Waart AB, van de Weem NM, Maas F, Kramer CS, Kester MG, Falkenburg JH, Schaap N, Jansen JH, van der Voort R, Gattinoni L, Hobo W, Dolstra H. van der Waart AB, et al. Among authors: van de weem nm, van der voort r. Blood. 2014 Nov 27;124(23):3490-500. doi: 10.1182/blood-2014-05-578583. Epub 2014 Oct 21. Blood. 2014. PMID: 25336630 Free PMC article.
siRNA silencing of PD-1 ligands on dendritic cell vaccines boosts the expansion of minor histocompatibility antigen-specific CD8(+) T cells in NOD/SCID/IL2Rg(null) mice.
van der Waart AB, Fredrix H, van der Voort R, Schaap N, Hobo W, Dolstra H. van der Waart AB, et al. Among authors: van der voort r. Cancer Immunol Immunother. 2015 May;64(5):645-54. doi: 10.1007/s00262-015-1668-6. Epub 2015 Feb 28. Cancer Immunol Immunother. 2015. PMID: 25724840 Free PMC article.
Combined IL-15 and IL-12 drives the generation of CD34+-derived natural killer cells with superior maturation and alloreactivity potential following adoptive transfer.
Cany J, van der Waart AB, Spanholtz J, Tordoir M, Jansen JH, van der Voort R, Schaap NM, Dolstra H. Cany J, et al. Among authors: van der voort r, van der waart ab. Oncoimmunology. 2015 Apr 1;4(7):e1017701. doi: 10.1080/2162402X.2015.1017701. eCollection 2015 Jul. Oncoimmunology. 2015. PMID: 26140247 Free PMC article.
21 results